tiprankstipranks
Advertisement
Advertisement
Beacon Biosignals Highlights Objective Sleep Biomarkers in MDD Drug Development
PremiumPrivate CompaniesBeacon Biosignals Highlights Objective Sleep Biomarkers in MDD Drug Development
14d ago
Beacon Biosignals Highlights Objective Sleep Biomarkers in Depression Drug Development
Premium
Private Companies
Beacon Biosignals Highlights Objective Sleep Biomarkers in Depression Drug Development
14d ago
Beacon Biosignals Showcases EEG Waveband at Major Neurology Conference
Premium
Private Companies
Beacon Biosignals Showcases EEG Waveband at Major Neurology Conference
15d ago
Beacon Biosignals Extends Series B to $97 Million to Scale At‑Home EEG Platform
PremiumPrivate CompaniesBeacon Biosignals Extends Series B to $97 Million to Scale At‑Home EEG Platform
29d ago
Beacon Biosignals Expands Series B Financing to $97 Million, Total Funding Reaches $132 Million
Premium
Private Companies
Beacon Biosignals Expands Series B Financing to $97 Million, Total Funding Reaches $132 Million
29d ago
Large-Scale Sleep-Wake Deal Highlights Growing Interest in Orexin-Based Therapies
Premium
Private Companies
Large-Scale Sleep-Wake Deal Highlights Growing Interest in Orexin-Based Therapies
1M ago
Beacon Biosignals Showcases EEG Technology and Parkinson’s Research at ADPD2026
PremiumPrivate CompaniesBeacon Biosignals Showcases EEG Technology and Parkinson’s Research at ADPD2026
2M ago
Beacon Biosignals Highlights New Parkinson’s REM Sleep Biomarker Research at AD/PD 2026
Premium
Private Companies
Beacon Biosignals Highlights New Parkinson’s REM Sleep Biomarker Research at AD/PD 2026
2M ago
Beacon Biosignals Highlights At-Home EEG Parkinson’s Research at AD/PD 2026
Premium
Private Companies
Beacon Biosignals Highlights At-Home EEG Parkinson’s Research at AD/PD 2026
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100